Tolerance and Outcomes of Neoadjuvant Chemotherapy in Geriatric Breast Cancer Patients
Author:
Publisher
Elsevier BV
Subject
Microbiology (medical),Immunology,Immunology and Allergy
Reference25 articles.
1. Breast cancer statistics, 2019;DeSantis;CA Cancer J Clin,2019
2. Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study;Kiderlen;Breast Cancer Res Treat,2014
3. Breast cancer treatment guidelines in older women;Giordano;J Clin Oncol,2005
4. When and how do I use neoadjuvant chemotherapy for breast cancer?;Rapoport;Curr Treat Options Oncol,2014
5. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the cancer and leukemia group B experience;Muss;J Clin Oncol,2007
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022;The Breast;2024-08
2. Octogenarians with triple negative breast cancer;Annals of Breast Surgery;2024-06
3. Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?;Annals of Surgical Oncology;2024-01-25
4. Predictive value of pre-operative prognostic nutritional index and systemic immune-inflammation index for efficacy and survival in patients with non-small cell lung cancer undergoing neoadjuvant chemotherapy;American Journal of Translational Research;2024
5. Curative effect of immediate reconstruction after neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3